CAPITAL Chemist Group has announced the extension of its trading partnership with pharmaceutical wholesaler, Symbion.
After signing a new five-year deal with the EBOS-owned wholesaler, Capital Chemist Group Business Manager, Andrew Topp, told Pharmacy Daily, the two businesses had fostered strong ties over the last seven years, with Symbion's support during the bushfire crisis earlier this year highlighting the "deep mutual respect" the companies have for each other.
"We have been trading with Symbion since 2014.
"The main reason we originally moved to Symbion was to access their 'retail execution excellence' such as planograms, promotional calendars, retail-ready programs and the like.
"These elements are still of great importance to us.
"Whilst Symbion's support to Capital Chemist during the bushfires was overwhelmingly generous, this was a manifestation of the deep mutual respect and friendship held by both parties for each other.
"This respect and friendship, and a collaborative spirit was the main driver for us to engage directly with them to build a new agreement.
"Our group is proudly different; we make our conversations all about health (and less about price); Symbion understand this and this is enormously valuable to our partners.
"With the timing of the signing of the Seventh Community Pharmacy Agreement, and the uncertainty caused by COVID-19, signing a new deal was definitely the right thing to do."
In a comment posted on LinkedIn in response to the new deal, Symbion CEO, Brett Barons said the wholesaler was proud of its partnership with Captial Chemists and its role in connecting the group with the communities they work in.
The above article was sent to subscribers in Pharmacy Daily's issue from 02 Sep 20
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Sep 20
